HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bertan Bopp Selected Research

Leukemia

5/2022Development of a First-in-Class Small-Molecule Inhibitor of the C-Terminal Hsp90 Dimerization.
1/2018Targeting HSP90 dimerization via the C terminus is effective in imatinib-resistant CML and lacks the heat shock response.
6/2015Naphthol AS-E Phosphate Inhibits the Activity of the Transcription Factor Myb by Blocking the Interaction with the KIX Domain of the Coactivator p300.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Bertan Bopp Research Topics

Disease

3Leukemia
05/2022 - 06/2015
3Neoplasms (Cancer)
06/2016 - 05/2013

Drug/Important Bio-Agent (IBA)

1Tyrosine Kinase InhibitorsIBA
05/2022
1PeptidomimeticsIBA
01/2018
1naphthol AS-E phosphateIBA
06/2015
1Casein Kinase II (Casein Kinase 2)IBA
05/2013
1Phosphotransferases (Kinase)IBA
05/2013

Therapy/Procedure

3Therapeutics
05/2022 - 06/2016
1Heterologous Transplantation (Xenotransplantation)
05/2022